Erratum: Scientific quality of COVID-19 and SARS CoV-2 publications in the highest impact medical journals during the early phase of the pandemic: A case control study (PLoS ONE (2020) 15:11 (e0241826) DOI: 10.1371/journal.pone.0241826);Scientific quality of COVID-19 and SARS CoV-2 publications in the highest impact medical journals during the early phase of the pandemic: A case control study

PLoS ONE

Volumn 15, Issue 11 November, 2020, Pages

  Zdravkovic, Marko ^a   Berger Estilita, Joana ^b   Zdravkovic, Bogdan ^a   Berger, David ^b  

^a UNIVERSITY MEDICAL CENTRE MARIBOR   (Slovenia)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CORONAVIRUS DISEASE 2019; EVIDENCE BASED PRACTICE; HUMAN; MEDICAL LITERATURE; NONHUMAN; PANDEMIC; PRACTICE GUIDELINE; PUBLICATION; QUALITY CONTROL; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; SYSTEMATIC REVIEW; BETACORONAVIRUS; CORONAVIRUS INFECTION; VIRUS PNEUMONIA;

BETACORONAVIRUS; CORONAVIRUS INFECTIONS; MEDICAL WRITING; PANDEMICS; PERIODICALS AS TOPIC; PNEUMONIA, VIRAL; PUBLICATIONS;

EID: 85095765344     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0250141     Document Type: Erratum

References (63)

1. Hossain MM. Current Status of Global Research on Novel Coronavirus Disease (COVID-19): A Bibliometric Analysis and Knowledge Mapping https://ssrncom/abstract=3547824. 2020.
2. Brown A, Horton R. A planetary health perspective on COVID-19: A call for papers. Lancet Planet Health. 2020.
3. Greaves S. Sharing findings related to COVID-19 in these extraordinary times www.hindawi.com: Hindawi; [19th April 2020]. https://www.hindawi.com/post/sharing-findings-related-covid-19-theseextraordinary-times/.
4. PLOS. A message to our community regarding COVID-19 plos.org: PLOS; [updated 19th March, 202019th April, 2020]. https://plos.org/blog/announcement/a-message-to-our-community-regardingcovid-19/.
5. Rothe C, Schunk M, Sothmann P, Bretzel G, Froeschl G, Wallrauch C, et al. Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany. N Eng J Med. 2020; 382(10):970-1. https://doi.org/10.1056/NEJMc2001468 PMID: 32003551
6. Kupferschmidt K. Study claiming new coronavirus can be transmitted by people without symptoms was flawed sciencemag.org2020 [19th April, 2020]. https://www.sciencemag.org/news/2020/02/paper-nonsymptomatic-patient-transmitting-coronavirus-wrong.
7. Zeng Y, Zhen Y. RETRACTED: Chinese medical staff request international medical assistance in fighting against COVID-19. Lancet Glob Health. 2020. https://doi.org/10.1016/S2214-109X(20)30065-6 PMID: 32105614
8. Mehra MR, Ruschitzka F, Patel AN. Retraction-Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: A multinational registry analysis. The Lancet. 2020; 395 (10240):1820.
9. Mehra MR, Desai SS, Kuy S, Henry TD, Patel AN. Retraction: Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19. N Engl J Med. https://doi.org/10.1056/NEJMoa2007621 New England Journal of Medicine. 2020; 382(26):2582-. PMID: 32356626
10. London AJ, Kimmelman J. Against pandemic research exceptionalism. Science (New York, NY). 2020. https://doi.org/10.1126/science.abc1731 PMID: 32327600
11. Kim AHJ, Sparks JA, Liew JW, Putman MS, Berenbaum F, Duarte-Garcia A, et al. A Rush to Judgment? Rapid Reporting and Dissemination of Results and Its Consequences Regarding the Use of Hydroxychloroquine for COVID-19. Ann Intern Med. 2020.
12. Angus DC. Optimizing the Trade-off Between Learning and Doing in a Pandemic. JAMA. 2020. https://doi.org/10.1001/jama.2020.4984 PMID: 32227198
13. Kalil AC. Treating COVID-19-Off-Label Drug Use, Compassionate Use, and Randomized Clinical Trials During Pandemics. JAMA. 2020.
14. Alhazzani W, Moller MH, Arabi YM, Loeb M, Gong MN, Fan E, et al. Surviving Sepsis Campaign: Guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19). Intensive Care Med. 2020.
15. Lamontagne F, Angus DC. Toward Universal Deployable Guidelines for the Care of Patients With COVID-19. JAMA. 2020. https://doi.org/10.1001/jama.2020.5110 PMID: 32215641
16. Johansson MA, Saderi D. Open peer-review platform for COVID-19 preprints. Nature. 2020; 579 (7797):29. https://doi.org/10.1038/d41586-020-00613-4 PMID: 32127711
17. Adare A, Afanasiev S, Aidala C, Ajitanand NN, Akiba Y, Al-Bataineh H, et al. Enhanced production of direct photons in Au + Au collisions at square root(S(NN)) = 200 GeV and implications for the initial temperature. Phys Rev Lett. 2010; 104(13):132301. https://doi.org/10.1103/PhysRevLett.104.132301 PMID: 20481877
18. Ioannidis JPA. Coronavirus disease 2019: The harms of exaggerated information and non-evidencebased measures. Eur J Clin Invest. 2020:e13223.
19. Goodman JL, Borio L. Finding Effective Treatments for COVID-19: Scientific Integrity and Public Confidence in a Time of Crisis. JAMA. 2020.
20. Bradshaw CJ, Brook BW. How to Rank Journals. PLoS One. 2016; 11(3):e0149852. https://doi.org/10. 1371/journal.pone.0149852 PMID: 26930052
21. Ioannidis JPA, Thombs BD. A user's guide to inflated and manipulated impact factors. Eur J Clin Invest. 2019; 49(9):e13151. https://doi.org/10.1111/eci.13151 PMID: 31206647
22. Phillips B, Ball C, Sackett D, Badenoch D, Straus S, Haynes B, et al. Oxford centre for evidence-based medicine-levels of evidence (March 2009). 2009.
23. Lander B, Balka E. Exploring How Evidence is Used in Care Through an Organizational Ethnography of Two Teaching Hospitals. Journal of medical Internet research. 2019; 21(3):e10769. https://doi.org/10. 2196/10769 PMID: 30920371
24. Djulbegovic B, Guyatt GH. Progress in evidence-based medicine: A quarter century on. Lancet. 2017; 390(10092):415-23. https://doi.org/10.1016/S0140-6736(16)31592-6 PMID: 28215660
25. Understanding qualitative research in health care. Drug and Therapeutics Bulletin. 2017; 55(2):21. https://doi.org/10.1136/dtb.2017.2.0457 PMID: 28183724
26. Concato J, Shah N, Horwitz RI. Randomized, controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med. 2000; 342(25):1887-92. https://doi.org/10.1056/NEJM200006223422507 PMID: 10861325
27. Kmet LM, Cook LS, Lee RC. Standard quality assessment criteria for evaluating primary research papers from a variety of fields. 2004.
28. Khan KS, Ter Riet G, Glanville J, Sowden AJ, Kleijnen J. Undertaking systematic reviews of research on effectiveness: CRD's guidance for carrying out or commissioning reviews: NHS Centre for Reviews and Dissemination; 2001.
29. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. Meta-analysis of observational studies in epidemiology: A proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000; 283(15):2008-12. https://doi.org/10.1001/jama.283.15.2008 PMID: 10789670
30. Falagas ME, Pitsouni EI, Malietzis GA, Pappas G. Comparison of PubMed, Scopus, web of science, and Google scholar: Strengths and weaknesses. FASEB J. 2008; 22(2):338-42. https://doi.org/10. 1096/fj.07-9492LSF PMID: 17884971
31. Martin-Martin A, Orduna-Malea E, Harzing A-W, López-Cózar ED. Can we use Google Scholar to identify highly-cited documents? J Informetr. 2017; 11(1):152-63.
32. Zdravkovic M, Osinova D, Brull SJ, Prielipp RC, Simoes CM, Berger-Estilita J, et al. Perceptions of gender equity in departmental leadership, research opportunities, and clinical work attitudes: An international survey of 11 781 anaesthesiologists. Br J Anaesth. 2020.
33. Marshall KH, D'UdekemY, Sholler GF, Opotowsky AR, Costa DS, Sharpe L, et al. Health-Related Quality of Life in Children, Adolescents, and Adults With a Fontan Circulation: A Meta-Analysis. J Am Heart Assoc. 2020; 9(6):e014172.
34. Brennan ME, Gormally JF, Butow P, Boyle FM, Spillane AJ. Survivorship care plans in cancer: A systematic review of care plan outcomes. Br J Cancer. 2014; 111(10):1899-908. https://doi.org/10.1038/bjc.2014.505 PMID: 25314068
35. Durlak JA. How to Select, Calculate, and Interpret Effect Sizes. Journal of Pediatric Psychology. 2009; 34(9):917-28. https://doi.org/10.1093/jpepsy/jsp004 PMID: 19223279
36. Sawilowsky SS. New effect size rules of thumb. J Mod Appl Stat Methods. 2009; 8(2):26.
37. Glen S. Hegde's g: Definition, Formula [August 11th, 2020]. https://www.statisticshowto.com/hedges-g/.
38. Zhang Y, Xiao M, Zhang S, Xia P, Cao W, Jiang W, et al. Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19. N Engl J Med. 2020; 382(17):e38. https://doi.org/10.1056/NEJMc2007575 PMID: 32268022
39. Alwan NA, Bhopal R, Burgess RA, Colburn T, Cuevas LE, Smith GD, et al. Evidence informing the UK's COVID-19 public health response must be transparent. Lancet. 2020; 395(10229):1036-7. https://doi. org/10.1016/S0140-6736(20)30667-X PMID: 32197104
40. nick.white@covid19crc.org C-CRCEa. Global coalition to accelerate COVID-19 clinical research in resource-limited settings. Lancet. 2020; 395(10233):1322-5. https://doi.org/10.1016/S0140-6736(20) 30798-4 PMID: 32247324
41. Cao B, Wang Y, Wen D, Liu W, Wang J, Fan G, et al. A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19. N Engl J Med. 2020. https://doi.org/10.1056/NEJMoa2001282 PMID: 32187464
42. Grasselli G, Zangrillo A, Zanella A, Antonelli M, Cabrini L, Castelli A, et al. Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy. JAMA. 2020. https://doi.org/10.1001/jama.2020.5394 PMID: 32250385
43. Grein J, Ohmagari N, Shin D, Diaz G, Asperges E, Castagna A, et al. Compassionate Use of Remdesivir for Patients with Severe Covid-19. N Engl J Med. 2020. https://doi.org/10.1056/NEJMoa2007016 PMID: 32275812
44. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study. Lancet. 2020; 395(10229):1054-62. https://doi.org/10.1016/S0140-6736(20)30566-3 PMID: 32171076
45. Bhatraju PK, Ghassemieh BJ, Nichols M, Kim R, Jerome KR, Nalla AK, et al. Covid-19 in Critically Ill Patients in the Seattle Region-Case Series. New England Journal of Medicine. 2020; 382(21):2012-22. https://doi.org/10.1056/NEJMoa2004500 PMID: 32227758
46. Ghinai I, McPherson TD, Hunter JC, Kirking HL, Christiansen D, Joshi K, et al. First known person-toperson transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the USA. Lancet. 2020; 395(10230):1137-44.
47. Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia. N Engl J Med. 2020; 382(13):1199-207. https://doi.org/10. 1056/NEJMoa2001316 PMID: 31995857
48. McMichael TM, Currie DW, Clark S, Pogosjans S, Kay M, Schwartz NG, et al. Epidemiology of Covid-19 in a Long-Term Care Facility in King County, Washington. N Engl J Med. 2020.
49. Pan A, Liu L, Wang C, Guo H, Hao X, Wang Q, et al. Association of Public Health Interventions With the Epidemiology of the COVID-19 Outbreak in Wuhan, China. Jama. 2020. https://doi.org/10.1001/jama. 2020.6130 PMID: 32275295
50. Pung R, Chiew CJ, Young BE, Chin S, Chen MI, Clapham HE, et al. Investigation of three clusters of COVID-19 in Singapore: Implications for surveillance and response measures. Lancet. 2020; 395 (10229):1039-46. https://doi.org/10.1016/S0140-6736(20)30528-6 PMID: 32192580
51. Gilbert M, Pullano G, Pinotti F, Valdano E, Poletto C, Boelle PY, et al. Preparedness and vulnerability of African countries against importations of COVID-19: A modelling study. Lancet. 2020; 395(10227):871-7. https://doi.org/10.1016/S0140-6736(20)30411-6 PMID: 32087820
52. Kandel N, Chungong S, Omaar A, Xing J. Health security capacities in the context of COVID-19 outbreak: An analysis of International Health Regulations annual report data from 182 countries. Lancet. 2020; 395(10229):1047-53. https://doi.org/10.1016/S0140-6736(20)30553-5 PMID: 32199075
53. Leung K, Wu JT, Liu D, Leung GM. First-wave COVID-19 transmissibility and severity in China outside Hubei after control measures, and second-wave scenario planning: A modelling impact assessment. Lancet. 2020; 395(10233):1382-93. https://doi.org/10.1016/S0140-6736(20)30746-7 PMID: 32277878
54. Grein J, Ohmagari N, Shin D, Diaz G, Asperges E, Castagna A, et al. Compassionate Use of Remdesivir for Patients with Severe Covid-19. New England Journal of Medicine. 2020. https://doi.org/10.1056/NEJMoa2007016 PMID: 32275812
55. Bhatraju PK, Ghassemieh BJ, Nichols M, Kim R, Jerome KR, Nalla AK, et al. Covid-19 in Critically Ill Patients in the Seattle Region-Case Series. N Engl J Med. 2020. https://doi.org/10.1056/NEJMoa2004500 PMID: 32227758
56. Pung R, Chiew CJ, Young BE, Chin S, Chen MI, Clapham HE, et al. Investigation of three clusters of COVID-19 in Singapore: Implications for surveillance and response measures. Lancet. 2020; 395 (10229):1039-46. https://doi.org/10.1016/S0140-6736(20)30528-6 PMID: 32192580
57. Jüni P, Witschi A, Bloch R, Egger M. The Hazards of Scoring the Quality of Clinical Trials for Meta-analysis. JAMA. 1999; 282(11):1054-60. https://doi.org/10.1001/jama.282.11.1054 PMID: 10493204
58. Shamoo AE. Validate the integrity of research data on COVID 19. Accountability in Research. 2020; 27 (6):325-6. https://doi.org/10.1080/08989621.2020.1787838 PMID: 32579869
59. Kalil AC. Treating COVID-19-Off-Label Drug Use, Compassionate Use, and Randomized Clinical Trials During Pandemics. JAMA. 2020.
60. Stockman LJ, Bellamy R, Garner P. SARS: Systematic review of treatment effects. PLoS Med. 2006; 3 (9):e343. https://doi.org/10.1371/journal.pmed.0030343 PMID: 16968120
61. Zagury-Orly I, Schwartzstein RM. Covid-19-A Reminder to Reason. N Engl J Med. 2020. https://doi. org/10.1056/NEJMp2009405 PMID: 32343505
62. Maguire BJ, Guerin PJ. A living systematic review protocol for COVID-19 clinical trial registrations. Wellcome Open Res. 2020; 5:60. https://doi.org/10.12688/wellcomeopenres.15821.1 PMID: 32292826
63. Lipsitch M, Swerdlow DL, Finelli L. Defining the Epidemiology of Covid-19-Studies Needed. N Engl J Med. 2020; 382(13):1194-6. https://doi.org/10.1056/NEJMp2002125 PMID: 32074416